CEO of California Stem Cell Agency Quits Abruptly; No Interim Replacement Named by Governing Board
Maria T. Millan gives no reason for departure next week
(Editor’s note: This is a complete write-through of the earlier news about Millan’s resignation and includes additional details.)
Maria T. Millan, president and CEO of the $12 billion California stem cell and gene therapy research program, has resigned effective a week from this Friday in an abrupt move that left the program wit…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.